XML 49 R22.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Earnings Per Share | 12 Months Ended
--- | ---
Dec. 31, 2018
Earnings Per Share [Abstract] |
Earnings Per Share | Footnote 15 — Earnings Per Share The computations of the weighted average shares outstanding for the years ended December 31, are as follows (in millions):
|  | 2018 |  |  | 2017 |  |  | 2016 |
Weighted-average shares outstanding |  |  | 473.3 |  |  |  | 485.7 |  |  |  | 418.3 |
Share-based payment awards classified as participating securities |  |  | 0.4 |  |  |  | 1.0 |  |  |  | 1.5 |
Dilutive effect from Jarden Acquisition |  |  | — |  |  |  | — |  |  |  | 1.5 |
Basic weighted-average shares outstanding |  |  | 473.7 |  |  |  | 486.7 |  |  |  | 421.3 |
Dilutive securities (1) |  |  | — |  |  |  | 1.3 |  |  |  | — |
Diluted weighted-average shares outstanding |  |  | 473.7 |  |  |  | 488.0 |  |  |  | 421.3 |
(1) | For 2018, 0.6 million potentially dilutive share-based awards are excluded as their effect would be anti-dilutive. For 2017 and 2016, the amount of potentially dilutive securities that are excluded because their effect would be anti-dilutive are not material.
As of December 31, 2018, there were 1.6 million potentially dilutive restricted share awards with performance-based vesting targets that were not met and as such, have been excluded from the computation of diluted earnings per share. For 2018, 2017 and 2016 dividends and equivalents for share-based awards expected to be forfeited did not have a material impact on net income for basic and diluted earnings per share. At December 31, 2018, there were approximately 2.5 million shares of the Company’s common stock that had not been issued to the former holders of Jarden shares who are exercising their right to judicial appraisal under Delaware law. Absent consent by the Company, these dissenting shareholders are no longer entitled to the merger consideration, but are instead entitled only to the judicially determined fair value of their shares, plus interest accruing from the date of the acquisition of Jarden, payable in cash (see Footnote 20).

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration